Farmacia
Facultad
María
Sanjurjo Sáez
Publicaciones en las que colabora con María Sanjurjo Sáez (97)
2023
-
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors
European Journal of Hospital Pharmacy
-
Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department
Hospital Pharmacy, Vol. 58, Núm. 1, pp. 106-110
-
Hacia la excelencia en la atención farmacéutica al paciente quirúrgico
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30
-
Presence of metallic components in transdermal drug delivery systems and risk of skin burns
Farmacia Hospitalaria
-
Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study
Pharmacological Reports, Vol. 75, Núm. 5, pp. 1254-1264
2022
-
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital
Frontiers in Public Health, Vol. 10
-
Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid
Annals of Pharmacotherapy, Vol. 56, Núm. 4, pp. 401-411
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
-
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale
JMIR mHealth and uHealth, Vol. 10, Núm. 2
-
PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort
Biomedicine and Pharmacotherapy, Vol. 146
-
Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientes
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 173-181
-
Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease
Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 4, pp. 548-551
2021
-
Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective
Frontiers in Oncology, Vol. 11
-
Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study
BMC Pulmonary Medicine, Vol. 21, Núm. 1
-
Dpyd exome, mrna expression and uracil levels in early severe toxicity to fluoropyrimidines: An extreme phenotype approach
Journal of Personalized Medicine, Vol. 11, Núm. 8
-
La importancia de los casos clínicos para la Farmacia Hospitalaria
Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 6, Núm. 2, pp. 1-1
-
Levels of tacrolimus after treatment for chronic hepatitis C with direct antiviral agents in solid organ transplant recipients
International Journal of Clinical Pharmacy, Vol. 43, Núm. 3, pp. 731-736
-
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease
Journal of Oncology Pharmacy Practice, Vol. 27, Núm. 3, pp. 751-755
2020
-
Assessing apps for patients with genitourinary tumors using the mobile application rating scale (MARS): Systematic search in app stores and content analysis
JMIR mHealth and uHealth, Vol. 8, Núm. 7
-
Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app
Journal of Oncology Pharmacy Practice, Vol. 26, Núm. 1, pp. 105-115